A new survey shows that nearly a third of women have been unable to get their pierced nipples pierced because of the cost of the implants.
In the survey, conducted by the UK-based UK Breast Cancer Society, the majority of women with pierced nipples said that their health was affected by the implants because they were expensive and had a high chance of complications.
Almost a quarter of women said they were unable to afford to get the implants in their local area because they could not afford to go to a specialist, said the report.
“Women are increasingly aware that they are the target of a number of different medical treatments that are often expensive and often not recommended by specialists,” said Dr Caroline O’Brien, co-founder of the Breast Cancer UK charity.
“The implants are expensive, the procedures are expensive and the risks are high, and that can make it hard for women to access their breasts.”
But the survey also showed that many women were still trying to get it done.
Of the 979 women who answered, more than one in five said they had tried a nipple piercing at some point but were unable due to cost.
The majority of those who said they tried a piercing had the same issue, with only 25% of women who said the procedure was too expensive to get said they could afford it.
The survey also found that the average cost of a nipple piercings in the UK is around £50,000, with a higher number of people saying they could find a local provider.
While breast cancer remains the second most common cancer diagnosed in the country, the report said that the majority (69%) of women diagnosed with the disease in 2016 had a breast cancer that did not affect their quality of life.
Dr O’Brian said the survey showed that the NHS was failing to prioritise breast cancer patients and that more than 50,000 women would be at risk of a recurrence.
“While we are at a point in time where the NHS are doing a lot more than they should, we’re not doing a good enough job of prioritising breast cancer and this survey suggests that this needs to change,” she said.
“Nipple piercing is a powerful and effective way of helping women with breast cancer get the help they need.”
It’s important that the government gets the message and gets on board and prioritises breast cancer as a cancer treatment and not just a cosmetic surgery.
“Nipple piercINGS, as the new breast cancer therapy is known, uses implants to stimulate breast tissue in the nipple to create a small blood vessel called a blood vessel cushion.
The implants can also create a blood supply to the breast which can be used to increase the flow of blood in the body, and to make the nipple smaller and easier to access.
Dr Olivia Smith, the director of research and policy at the Breast Foundation, said she was encouraged by the results.”
I was really pleased to see a very high proportion of women saying they had had a successful operation and the numbers are just getting bigger,” she told the BBC.”
There are now more than 400,000 people waiting for the NHS to provide breast cancer screening services in England and it’s fantastic to see so many women are finding out that their breasts have grown back.
“A spokeswoman for the Breast Care and Research Institute, which commissioned the survey of women, said they believed that many of the women surveyed were already having successful operations and were looking for a new method to help them get a nipple pierced.”
She said that in the longer term, it would be important to make sure that the new therapy was used more widely in the NHS.””
We recognise that the breast cancer service is one of the most important parts of our care, and we continue to encourage women with cancer to seek the support they need to make a successful and successful recovery.”
She said that in the longer term, it would be important to make sure that the new therapy was used more widely in the NHS.
“We’re hoping that the data from this survey will be used by the NHS as part of a more rigorous research review of the breast piercing treatment, which will include data from the NHS’s own clinical trials,” the spokesperson said.